These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9717193)

  • 21. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
    Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulated lymphoproliferation coincides with parasite maturation and with the collapse of both gamma interferon and interleukin-4 responses in a bovine model of onchocerciasis.
    Graham SP; Trees AJ; Collins RA; Moore DM; Guy FM; Taylor MJ; Bianco AE
    Infect Immun; 2001 Jul; 69(7):4313-9. PubMed ID: 11401968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.
    Soboslay PT; Geiger SM; Drabner B; Banla M; Batchassi E; Kowu LA; Stadler A; Schulz-Key H
    Clin Exp Immunol; 1999 Jul; 117(1):130-7. PubMed ID: 10403926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
    Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
    Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
    Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
    Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA immunisation with Onchocerca volvulus chitinase induces partial protection against challenge infection with L3 larvae in mice.
    Harrison RA; Wu Y; Egerton G; Bianco AE
    Vaccine; 1999 Nov; 18(7-8):647-55. PubMed ID: 10547424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Onchocerca volvulus keratitis (river blindness) is exacerbated in BALB/c IL-4 gene knockout mice.
    Hall LR; Berger RB; Diaconu E; Pearlman E
    Cell Immunol; 2002; 216(1-2):1-5. PubMed ID: 12381344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo molecular analysis of cytokines in a murine model of ocular onchocerciasis. I. Up-regulation of IL-4 and IL-5 mRNAs and not IL-2 and IFN gamma mRNAs in the cornea due to experimental interstitial keratitis.
    Chakravarti B; Lagoo-Deenadayalan S; Parker JS; Whitfield DR; Lagoo A; Chakravarti DN
    Immunol Lett; 1996 Dec; 54(1):59-64. PubMed ID: 9030983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of larval-stage-specific antigens of Onchocerca volvulus uniquely recognized by putative immune sera from humans and vaccination sera from animal models.
    Irvine M; Johnson EH; Lustigman S
    Ann Trop Med Parasitol; 1997 Jan; 91(1):67-77. PubMed ID: 9093431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease.
    Lüder CG; Schulz-Key H; Banla M; Pritze S; Soboslay PT
    Clin Exp Immunol; 1996 Aug; 105(2):245-53. PubMed ID: 8706329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA immunization with Onchocerca volvulus genes, Ov-tmy-1 and OvB20: serological and parasitological outcomes following intramuscular or GeneGun delivery in a mouse model of onchocerciasis.
    Harrison RA; Bianco AE
    Parasite Immunol; 2000 May; 22(5):249-57. PubMed ID: 10792764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cell responses in coinfection with Onchocerca volvulus and the human immunodeficiency virus type 1.
    Sentongo E; Rubaale T; Büttner DW; Brattig NW
    Parasite Immunol; 1998 Sep; 20(9):431-9. PubMed ID: 9767610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early human infection with Onchocerca volvulus is associated with an enhanced parasite-specific cellular immune response.
    Cooper PJ; Mancero T; Espinel M; Sandoval C; Lovato R; Guderian RH; Nutman TB
    J Infect Dis; 2001 Jun; 183(11):1662-8. PubMed ID: 11343216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Onchocerca volvulus: immunization of chimpanzees with X-irradiated third-stage (L3) larvae.
    Prince AM; Brotman B; Johnson EH; Smith A; Pascual D; Lustigman S
    Exp Parasitol; 1992 May; 74(3):239-50. PubMed ID: 1582477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eosinophil-larval-interaction in onchocerciasis: heterogeneity of in vitro adherence of eosinophils to infective third and fourth stage larvae and microfilariae of Onchocerca volvulus.
    Brattig NW; Tischendorf FW; Strote G; Medina-de la Garza CE
    Parasite Immunol; 1991 Jan; 13(1):13-22. PubMed ID: 2014134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift.
    Doetze A; Satoguina J; Burchard G; Rau T; Löliger C; Fleischer B; Hoerauf A
    Int Immunol; 2000 May; 12(5):623-30. PubMed ID: 10784608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-5 dominates cytokine responses during expression of protective immunity to Onchocerca lienalis microfilariae in mice.
    Hogarth PJ; Bianco AE
    Parasite Immunol; 1999 Feb; 21(2):81-8. PubMed ID: 10101718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis).
    Satoguina J; Mempel M; Larbi J; Badusche M; Löliger C; Adjei O; Gachelin G; Fleischer B; Hoerauf A
    Microbes Infect; 2002 Nov; 4(13):1291-300. PubMed ID: 12443893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Onchocerca ochengi: epidemiological evidence of cross-protection against Onchocerca volvulus in man.
    Wahl G; Enyong P; Ngosso A; Schibel JM; Moyou R; Tubbesing H; Ekale D; Renz A
    Parasitology; 1998 Apr; 116 ( Pt 4)():349-62. PubMed ID: 9585937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful vaccination against Onchocerca ochengi infestation in cattle using live Onchocerca volvulus infective larvae.
    Achukwi MD; Harnett W; Enyong P; Renz A
    Parasite Immunol; 2007 Mar; 29(3):113-6. PubMed ID: 17266738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.